GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses
Shreeram C. Nallar1, Sudhakar Kalakonda1, Peng Sun2 and Dhan V. Kalvakolanu1,2
1Department of Microbiology and Immunology, Marlene and Stewart Greenebaum Cancer Center, 2Molecular and Cellular Cancer Biology, Graduate Program in Life Sciences, University of Maryland School of Medicine, Baltimore, MD 21201.
Abstract
Gene associated with retinoid-interferon-β-induced mortality (GRIM)—19, was originally identifi ed as a critical regulatory protein necessary for Interferon-β-Retinoic acid-induced cell death. Overexpression of GRIM-19 activates cell death and its suppression or inactivation promotes cell growth. GRIM-19 targets multiple proteins/pathways for exerting growth control and cell death. However, GRIM-19 is also required for normal cellular processes. In addition, viruses ‘hijack’ GRIM-19 for their survival. Intracellular bacterial infections and bacterial products have been reported to induce the expression of GRIM-19. In this review, we will discuss the current status of GRIM-19 in growth control and innate immune response.
Readers of this also read:
- Six Genes Associated with the Clinical Phenotypes of Individuals with Deficient and Proficient DNA Repair
- Introductory Editorial (Journal of Experimental Neuroscience)
- Possible Imprinting and Microchimerism in Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders
- Oncogenic Role of Engrailed-2 (En-2) in Prostate Cancer Cell Growth and Survival
- Obesity, Adipocytokines and Cancer